Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors
Clinical trial NCT01340547 · UNKNOWN
Trial details
- NCT number
- NCT01340547
- Sponsor
- Alaunos Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-09-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.